Portal de Periódicos da CAPES

Colchicine and pseudogout

1980; Wiley; Volume: 23; Issue: 9 Linguagem: Inglês

10.1002/art.1780230917

1529-0131

Isaias Spilberg, David McLain, L Simchowitz, Steven Berney,

Rheumatoid Arthritis Research and Therapies

Arthritis & RheumatismVolume 23, Issue 9 p. 1062-1063 Brief ReportFree to Read Colchicine and pseudogout Isaias Spilberg MD, Corresponding Author Isaias Spilberg MD Associate Professor of Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.J.C. Veterans Administration Medical Center, Rheumatology Unit (151JC), 915 North Grand Avenue, St. Louis, MO 63106Search for more papers by this authorDavid Mclain MD, David Mclain MD Instructor in Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.Search for more papers by this authorLouis Simchowitz MD, Louis Simchowitz MD Assistant Professor of Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.Search for more papers by this authorSteven Berney MD, Steven Berney MD Associate Professor of Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.Search for more papers by this author Isaias Spilberg MD, Corresponding Author Isaias Spilberg MD Associate Professor of Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.J.C. Veterans Administration Medical Center, Rheumatology Unit (151JC), 915 North Grand Avenue, St. Louis, MO 63106Search for more papers by this authorDavid Mclain MD, David Mclain MD Instructor in Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.Search for more papers by this authorLouis Simchowitz MD, Louis Simchowitz MD Assistant Professor of Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.Search for more papers by this authorSteven Berney MD, Steven Berney MD Associate Professor of Medicine Medicine, the John Cochran Veterans Administration Medical Center, Washington University School of Medicine, and the Department of Medicine, Temple University School of Medicine.Search for more papers by this author First published: September 1980 https://doi.org/10.1002/art.1780230917Citations: 34AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Reference 1 McCarty DJ: Calcium pyrophosphate crystals deposition disease: pseudogout: articular chondrocalcinosis, Arthritis and Allied Conditions. Edited by DJ McCarty. Ninth edition. Philadelphia, Lea & Febiger, 1979, pp 1276 2 Spilberg I: Role of leukocytes and chemical mediators in the acute gouty attack, Uric Acid: Handbook of Experimental Pharmacology. Edited by IM Weiner, WN Kelley. New York, Springer-Verlag, 1978, pp 365–377 3 Spilberg I, Gallacher A, Mehta JM, Mandell B: Urate crystal-induced chemotactic factor: isolation and partial characterization. J Clin Invest 58: 815–819, 1976 4 Spilberg I, Gallacher A, Mandell B: Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor. J Lab Clin Med 89: 817–822, 1977 5 Spilberg I, Rosenberg D, Mandell B: Induction of arthritis by purified cell derived chemotactic factor. J Clin Invest 59: 582–585, 1977 6 Tse RL, Phelps P: Polymorphonuclear leukocyte motility in vitro: release of chemotactic activity following phagocytosis of calcium pyrophosphate, diamond dust and urate crystals. J Lab Clin Med 76: 403–414, 1970 7 Spilberg I, Gallacher A, Mandell B, Rosenberg D: A mechanism of action for nonsteroidal anti-inflammatory agents in calcium pyrophosphate dihydrate (CPPD) crystal induced arthritis. Agents Actions 7: 153–155, 1977 8 Spilberg I, Berney S: Colchicine and pseudogout (letter). Arthritis Rheum 22: 427–428, 1979 9 McCarty DJ: Synovial fluid, Arthritis and Allied Conditions. Edited by DJ McCarty. Ninth edition. Philadelphia, Lea & Febiger, 1979, pp 31 10 Wallace SE: Colchicine. Semin Arthritis Rheum 3: 369–381, 1974 11 Tabatabai MR, Cummings NA: Intravenous colchicine in the treatment of acute pseudogout. Arthritis Rheum 23: 370–374, 1980 12 Liu YK, Hymowitz, Carroll MG: Marrow aplasia induced by colchicine. Arthritis Rheum 21: 731–735, 1978 13 Spilberg I, Mandell B, Mehta JM, Simchowitz L, Rosenberg D: Mechanism of action of colchicine in acute urate crystal-induced arthritis. J Clin Invest 64: 775–780, 1979 Citing Literature Volume23, Issue9September 1980Pages 1062-1063 ReferencesRelatedInformation